Core Insights - Auna S.A.'s Peru business demonstrates the effectiveness of its integrated healthcare model, with a notable revenue increase of 11% year-over-year in Q4 2025, driven by high complexity services and investments in medical infrastructure [1][8] Financial Performance - Adjusted EBITDA for Auna S.A. in Peru rose by 14% in Q4 2025, achieving a margin of 22.4%, which is an improvement of 0.7 percentage points from Q4 2024 [2][8] - Oncosalud, Auna's health plan segment, saw revenues increase by 10%, supported by a 4% rise in planned memberships and annual price adjustments, with a record-low oncology Medical Loss Ratio (MLR) of 48.5% [3][8] Strategic Developments - Auna S.A. is focusing on growth in mid-segment markets and risk-sharing with payors, having finalized an addendum to its Public-Private Partnership with EsSalud, which will facilitate the Torre Trecca project in Lima [4] - The partnership with EsSalud, Peru's largest payor and provider, significantly expands Auna's addressable market [4] Market Position - Auna S.A. shares have increased by 5.7% year-to-date, contrasting with an 8.3% decline in the industry [7] - The company is currently trading at a forward price-to-sales (P/S) ratio of 0.28X, which is lower than both its median and industry average [9] Analyst Sentiment - Analysts have been raising earnings estimates for Auna S.A., indicating positive sentiment towards the company's future performance [11]

Group 1 - CVS Health will hold a conference call on July 31, 2025, at 8:00 a.m. ET to discuss its second quarter 2025 financial results [1] - An audio webcast of the conference call will be available on the CVS Health Investor Relations website and archived for one year [1] Group 2 - As of March 31, 2025, CVS Health operates over 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care medical clinics [2] - The company is a leading pharmacy benefits manager with approximately 88 million plan members and serves over 800,000 patients annually through its senior pharmacy care business [2] - CVS Health provides health insurance products and services to an estimated 37 million people, including Medicare Advantage offerings and a standalone Medicare Part D prescription drug plan [2] - The company's integrated model focuses on personalized, technology-driven services to enhance access to quality care, improve health outcomes, and reduce overall costs [2]